JPY 3515.0
(0.14%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 1.72 Billion JPY | 15.91% |
2022 | 1.49 Billion JPY | -9.15% |
2021 | 1.64 Billion JPY | -5.91% |
2020 | 1.74 Billion JPY | -0.91% |
2019 | 1.75 Billion JPY | -52.38% |
2018 | 3.69 Billion JPY | 1.68% |
2017 | 3.63 Billion JPY | 5.12% |
2016 | 3.45 Billion JPY | 4.63% |
2015 | 3.3 Billion JPY | 0.76% |
2014 | 3.27 Billion JPY | -0.06% |
2013 | 3.28 Billion JPY | -6.98% |
2012 | 3.52 Billion JPY | -3.34% |
2011 | 3.64 Billion JPY | -10.87% |
2010 | 4.09 Billion JPY | 16.71% |
2009 | 3.5 Billion JPY | 8.14% |
2008 | 3.24 Billion JPY | -78.13% |
2007 | 14.82 Billion JPY | 0.41% |
2006 | 14.76 Billion JPY | -39.85% |
2005 | 24.54 Billion JPY | 1.48% |
2004 | 24.19 Billion JPY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 1.26 Billion JPY | -5.97% |
2024 Q1 | 1.34 Billion JPY | -22.41% |
2023 Q4 | 1.72 Billion JPY | 24.24% |
2023 FY | 1.72 Billion JPY | 15.91% |
2023 Q3 | 1.39 Billion JPY | 0.0% |
2023 Q1 | 1.44 Billion JPY | -3.36% |
2023 Q2 | 1.39 Billion JPY | -3.47% |
2022 Q3 | 1.54 Billion JPY | -3.14% |
2022 Q4 | 1.49 Billion JPY | -3.25% |
2022 FY | 1.49 Billion JPY | -9.15% |
2022 Q1 | 1.64 Billion JPY | 0.0% |
2022 Q2 | 1.59 Billion JPY | -3.05% |
2021 FY | 1.64 Billion JPY | -5.91% |
2021 Q2 | 1.73 Billion JPY | -0.23% |
2021 Q4 | 1.64 Billion JPY | -5.26% |
2021 Q1 | 1.73 Billion JPY | -0.23% |
2021 Q3 | 1.73 Billion JPY | -0.23% |
2020 Q1 | 1.75 Billion JPY | -0.23% |
2020 Q4 | 1.74 Billion JPY | -0.23% |
2020 FY | 1.74 Billion JPY | -0.91% |
2020 Q2 | 1.75 Billion JPY | -0.23% |
2020 Q3 | 1.74 Billion JPY | -0.23% |
2019 Q1 | 3.68 Billion JPY | -0.24% |
2019 Q3 | 3.66 Billion JPY | -0.24% |
2019 Q4 | 1.75 Billion JPY | -52.03% |
2019 Q2 | 3.67 Billion JPY | -0.24% |
2019 FY | 1.75 Billion JPY | -52.38% |
2018 FY | 3.69 Billion JPY | 1.68% |
2018 Q4 | 3.69 Billion JPY | 1.46% |
2018 Q3 | 3.64 Billion JPY | 0.14% |
2018 Q1 | 3.63 Billion JPY | -0.03% |
2018 Q2 | 3.63 Billion JPY | 0.11% |
2017 Q3 | 3.6 Billion JPY | 1.69% |
2017 Q1 | 3.52 Billion JPY | 1.88% |
2017 Q4 | 3.63 Billion JPY | 0.92% |
2017 FY | 3.63 Billion JPY | 5.12% |
2017 Q2 | 3.54 Billion JPY | 0.54% |
2016 Q2 | 3.43 Billion JPY | 3.31% |
2016 Q3 | 3.47 Billion JPY | 1.05% |
2016 FY | 3.45 Billion JPY | 4.63% |
2016 Q1 | 3.32 Billion JPY | 0.7% |
2016 Q4 | 3.45 Billion JPY | -0.46% |
2015 Q3 | 3.31 Billion JPY | 1.31% |
2015 Q2 | 3.27 Billion JPY | 0.03% |
2015 Q1 | 3.26 Billion JPY | -0.27% |
2015 FY | 3.3 Billion JPY | 0.76% |
2015 Q4 | 3.3 Billion JPY | -0.3% |
2014 Q2 | 3.27 Billion JPY | 2.03% |
2014 Q3 | 3.23 Billion JPY | -0.95% |
2014 FY | 3.27 Billion JPY | -0.06% |
2014 Q4 | 3.27 Billion JPY | 1.2% |
2014 Q1 | 3.2 Billion JPY | -2.29% |
2013 Q1 | 3.49 Billion JPY | -0.85% |
2013 Q3 | 3.37 Billion JPY | -0.74% |
2013 Q4 | 3.28 Billion JPY | -2.81% |
2013 FY | 3.28 Billion JPY | -6.98% |
2013 Q2 | 3.4 Billion JPY | -2.75% |
2012 Q3 | 3.55 Billion JPY | -0.7% |
2012 Q2 | 3.57 Billion JPY | -1.27% |
2012 FY | 3.52 Billion JPY | -3.34% |
2012 Q1 | 3.62 Billion JPY | -0.69% |
2012 Q4 | 3.52 Billion JPY | -0.73% |
2011 FY | 3.64 Billion JPY | -10.87% |
2011 Q4 | 3.64 Billion JPY | -0.68% |
2011 Q2 | 3.69 Billion JPY | -5.49% |
2011 Q1 | 3.91 Billion JPY | -4.37% |
2011 Q3 | 3.67 Billion JPY | -0.7% |
2010 Q3 | 3.72 Billion JPY | -1.06% |
2010 FY | 4.09 Billion JPY | 16.71% |
2010 Q4 | 4.09 Billion JPY | 9.88% |
2010 Q2 | 3.76 Billion JPY | 2.62% |
2010 Q1 | 3.66 Billion JPY | 4.62% |
2009 Q3 | 3.28 Billion JPY | 2.59% |
2009 Q2 | 3.2 Billion JPY | 0.0% |
2009 FY | 3.5 Billion JPY | 8.14% |
2009 Q4 | 3.5 Billion JPY | 6.79% |
2008 Q3 | 2.8 Billion JPY | 0.0% |
2008 FY | 3.24 Billion JPY | -78.13% |
2008 Q4 | 3.24 Billion JPY | 15.45% |
2007 FY | 14.82 Billion JPY | 0.41% |
2006 FY | 14.76 Billion JPY | -39.85% |
2005 FY | 24.54 Billion JPY | 1.48% |
2004 FY | 24.19 Billion JPY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 16.89 Billion JPY | 89.776% |
Takeda Pharmaceutical Company Limited | 4843.75 Billion JPY | 99.964% |
Sumitomo Pharma Co., Ltd. | 418.88 Billion JPY | 99.588% |
Shionogi & Co., Ltd. | 11.62 Billion JPY | 85.138% |
Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -1617.912% |
Nippon Shinyaku Co., Ltd. | 2.87 Billion JPY | 39.868% |
Kaken Pharmaceutical Co., Ltd. | 3.85 Billion JPY | 55.143% |
Eisai Co., Ltd. | 206.74 Billion JPY | 99.165% |
Morishita Jintan Co., Ltd. | 425 Million JPY | -306.353% |
Hisamitsu Pharmaceutical Co., Inc. | 2.1 Billion JPY | 17.762% |
Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -368.022% |
Fuso Pharmaceutical Industries,Ltd. | 12.72 Billion JPY | 86.425% |
Nippon Chemiphar Co., Ltd. | 16.98 Billion JPY | 89.83% |
Tsumura & Co. | 79.69 Billion JPY | 97.833% |
Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -607.787% |
Towa Pharmaceutical Co., Ltd. | 202.35 Billion JPY | 99.147% |
Fuji Pharma Co., Ltd. | 28.94 Billion JPY | 94.034% |
Zeria Pharmaceutical Co., Ltd. | 47.58 Billion JPY | 96.371% |
KYORIN Holdings, Inc. | 20.94 Billion JPY | 91.755% |
Taiko Pharmaceutical Co.,Ltd. | 3.8 Billion JPY | 54.66% |
Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | 80.193% |
SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
MedRx Co., Ltd | - JPY | -Infinity% |
Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
Solasia Pharma K.K. | 60 Million JPY | -2778.333% |
Modalis Therapeutics Corporation | 412.5 Million JPY | -318.667% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | 81.792% |
Sawai Group Holdings Co., Ltd. | 82.89 Billion JPY | 97.917% |
Cyfuse Biomedical K.K. | 913 Million JPY | -89.157% |
Toho Holdings Co., Ltd. | 30.24 Billion JPY | 94.29% |
Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | 38.873% |